SE9100556D0 - Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans - Google Patents

Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans

Info

Publication number
SE9100556D0
SE9100556D0 SE9100556A SE9100556A SE9100556D0 SE 9100556 D0 SE9100556 D0 SE 9100556D0 SE 9100556 A SE9100556 A SE 9100556A SE 9100556 A SE9100556 A SE 9100556A SE 9100556 D0 SE9100556 D0 SE 9100556D0
Authority
SE
Sweden
Prior art keywords
coli
enterotoxigenic
humans
formalin
killed
Prior art date
Application number
SE9100556A
Other languages
English (en)
Swedish (sv)
Inventor
Jan Holmgrem
Ann-Mari Svennerholm
Original Assignee
Holmgren Jan
Svennerholm Ann Mari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holmgren Jan, Svennerholm Ann Mari filed Critical Holmgren Jan
Priority to SE9100556A priority Critical patent/SE9100556D0/xx
Publication of SE9100556D0 publication Critical patent/SE9100556D0/xx
Priority to DK92906078T priority patent/DK0573527T3/da
Priority to DE69226944T priority patent/DE69226944T2/de
Priority to ES92906078T priority patent/ES2123550T3/es
Priority to EP92906078A priority patent/EP0573527B1/en
Priority to KR1019930702564A priority patent/KR100221452B1/ko
Priority to SK910-93A priority patent/SK280919B6/sk
Priority to CA002104877A priority patent/CA2104877C/en
Priority to AU13308/92A priority patent/AU663864B2/en
Priority to RU93053899A priority patent/RU2127121C1/ru
Priority to US08/108,606 priority patent/US6558678B1/en
Priority to CS931742A priority patent/CZ281556B6/cs
Priority to AT92906078T priority patent/ATE170755T1/de
Priority to PCT/SE1992/000110 priority patent/WO1992014487A1/en
Priority to HU9302410A priority patent/HU213924B/hu
Priority to JP50610592A priority patent/JP3169608B2/ja
Priority to RO93-01142A priority patent/RO109819B1/ro
Priority to BR9205677A priority patent/BR9205677A/pt
Priority to OA60404A priority patent/OA09865A/en
Priority to NO933037A priority patent/NO307867B1/no
Priority to BG98070A priority patent/BG61683B1/bg
Priority to FI933728A priority patent/FI108775B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9100556A 1991-02-26 1991-02-26 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans SE9100556D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE9100556A SE9100556D0 (sv) 1991-02-26 1991-02-26 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans
BR9205677A BR9205677A (pt) 1991-02-26 1992-02-25 Processo de produçao de uma composiçao de vacina contra infecçao entérica provocada por bactérias de E. COLI enterotoxigenicas, e, processo para evitar a infecçao entérica
US08/108,606 US6558678B1 (en) 1991-02-26 1992-02-25 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
AT92906078T ATE170755T1 (de) 1991-02-26 1992-02-25 Darstellung und verwendung von mit formalin abgetöteten e. coli bakterien, die das kolonie- faktor-antigen (cfa) expremieren zur impfung gegen das die darminfektion/diarrhoe in menschen auslösende darmbakterium e. coli
ES92906078T ES2123550T3 (es) 1991-02-26 1992-02-25 Procedimiento para producir una composicion de vacuna contra infeccion enterica provocada por la bacteria enterotoxigenica e. coli en los humanos y que es adecuada para vacunacion contra la infeccion enterica/diarrea provocada por la bacteria enterotoxigenica e. coli en humanos.
EP92906078A EP0573527B1 (en) 1991-02-26 1992-02-25 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
KR1019930702564A KR100221452B1 (ko) 1991-02-26 1992-02-25 장감염에 대한 백신조성물의 제조방법
SK910-93A SK280919B6 (sk) 1991-02-26 1992-02-25 Spôsob výroby kompozitnej vakcíny proti črevnej infekcii spôsobenej enterotoxigénnymi baktériami e. coli u ľudí
CA002104877A CA2104877C (en) 1991-02-26 1992-02-25 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
AU13308/92A AU663864B2 (en) 1991-02-26 1992-02-25 Preparation and use of formalin-killed colonization-factor-antigen (CFA)-expressing E. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic E. coli bacteria in humans
RU93053899A RU2127121C1 (ru) 1991-02-26 1992-02-25 Способ получения вакцинной композиции против кишечной инфекции
DK92906078T DK0573527T3 (da) 1991-02-26 1992-02-25 Fremstilling og anvendelse af formalindræbte, kolonisationsfaktor-antigen(CFA)-udtrykkende E. coli-organismer til vaccinati
CS931742A CZ281556B6 (cs) 1991-02-26 1992-02-25 Způsob výroby kompozitní vakcíny proti střevní infekci způsobené enterotexigenickými bakteriemi E. coli
DE69226944T DE69226944T2 (de) 1991-02-26 1992-02-25 Darstellung und verwendung von mit formalin abgetöteten e. coli bakterien, die das kolonie-faktor-antigen (cfa) expremieren zur impfung gegen das die darminfektion/diarrhoe in menschen auslösende darmbakterium e. coli
PCT/SE1992/000110 WO1992014487A1 (en) 1991-02-26 1992-02-25 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
HU9302410A HU213924B (en) 1991-02-26 1992-02-25 Method for producing vaccine against enteric infection caused by enterotoxigenic e.coli bacteria in humans, containing formalin-killed e.coli strain having the ability of expressing colonization factor antigens
JP50610592A JP3169608B2 (ja) 1991-02-26 1992-02-25 ヒトにおいてエンテロトキシン産生大腸菌により起こる腸感染症／下痢に対して接種するためのホルマリン殺菌したコロニー形成因子抗原（ｃｆａ）−発現性大腸菌の調製および使用
RO93-01142A RO109819B1 (ro) 1991-02-26 1992-02-25 Metoda pentru obtinerea unui vaccin anti ecoli enterotoxigena
OA60404A OA09865A (en) 1991-02-26 1993-08-24 Preparation and use of formalin-killed colonization-factor-antigen (CFA)-expressing E. Coli Organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic E. Coli bacteria in humans.
NO933037A NO307867B1 (no) 1991-02-26 1993-08-25 FremgangsmÕte for fremstilling av et vaksinepreparat mot tarminfeksjon hos mennesker forÕrsaket av enterotoksigene E. coli- bakterier
BG98070A BG61683B1 (bg) 1991-02-26 1993-08-25 Получаване и използване на убити с формалин организми от видае. coli, експресиращи антиген на колонийобразуващия фактор, заваксиниране срещу чревни инфекции/диарии, причинени отентеротоксични бактерии на e. coli у хората
FI933728A FI108775B (fi) 1991-02-26 1993-08-25 Menetelmä enterotoksigeenisten E. coli -bakteereiden ihmisessä aiheuttamaa suolistoinfektiota vastaan vaikuttavan rokotekoostumuksen tuottamiseksi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100556A SE9100556D0 (sv) 1991-02-26 1991-02-26 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans

Publications (1)

Publication Number Publication Date
SE9100556D0 true SE9100556D0 (sv) 1991-02-26

Family

ID=20381987

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9100556A SE9100556D0 (sv) 1991-02-26 1991-02-26 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans

Country Status (22)

Country Link
US (1) US6558678B1 (sk)
EP (1) EP0573527B1 (sk)
JP (1) JP3169608B2 (sk)
KR (1) KR100221452B1 (sk)
AT (1) ATE170755T1 (sk)
AU (1) AU663864B2 (sk)
BG (1) BG61683B1 (sk)
BR (1) BR9205677A (sk)
CA (1) CA2104877C (sk)
CZ (1) CZ281556B6 (sk)
DE (1) DE69226944T2 (sk)
DK (1) DK0573527T3 (sk)
ES (1) ES2123550T3 (sk)
FI (1) FI108775B (sk)
HU (1) HU213924B (sk)
NO (1) NO307867B1 (sk)
OA (1) OA09865A (sk)
RO (1) RO109819B1 (sk)
RU (1) RU2127121C1 (sk)
SE (1) SE9100556D0 (sk)
SK (1) SK280919B6 (sk)
WO (1) WO1992014487A1 (sk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118758B1 (en) * 1997-01-24 2006-10-10 The United States Of America As Represented By The Secretary Of The Army Transformed bacteria producing CS6 antigens as vaccines
SE9401921D0 (sv) * 1994-06-03 1994-06-03 Sbl Vaccin Ab A method of cultivating bacteria
US7404961B2 (en) 1996-08-02 2008-07-29 The United States Of America As Represented By The Secretary Of The Army Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins
US7094883B1 (en) 1996-08-02 2006-08-22 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
US5994078A (en) * 1997-07-31 1999-11-30 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
SE515285C2 (sv) * 1998-12-18 2001-07-09 Sbl Vaccin Ab Oralt vaccin mot diarré
GB0121998D0 (en) * 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
ZA200604412B (en) * 2003-10-31 2007-09-26 Univ British Columbia Bacterial virulence factors and uses thereof
EP1981536A4 (en) * 2006-02-01 2012-03-14 Gotovax Ab ANTIGENS OF COLONIZATION FACTOR OF ESCHERICHIA COLI ENTEROTOXIGENES IN RECOMBINANT BACTERIA
EP2711013A4 (en) * 2011-05-18 2015-03-04 Ajinomoto Kk IMMUNSTIMULANDS FOR ANIMALS, FEED THEREFOR AND MANUFACTURING PROCESS THEREFOR
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
AU2011376755B2 (en) * 2011-09-12 2016-09-29 Scandinavian Biopharma Holding Ab Vaccine for protection against ETEC induced diarrhea comprising dmLT.
DK2750701T3 (en) 2011-09-12 2016-01-11 Scandinavian Biopharma Holding Ab PROCEDURE FOR INCREASING ETEC-CS6 ANTIGEN PRESENTATION ON CELL SURFACE AND THEREFORE AVAILABLE PRODUCTS
RO132299A3 (ro) 2017-06-06 2018-12-28 Fântână Raul Sorin Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD62894A (sk) *
DE1208038B (de) * 1963-08-01 1965-12-30 Wellcome Found Verfahren zur Herstellung von Impfstoffen gegen Coli-Infektionen
GB1472624A (en) 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4338298A (en) * 1980-04-04 1982-07-06 Endowment And Research Foundation At Montana State University Vaccine for passive immunization against enteric colibacillosis and method of use
DK41885A (da) * 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
IL79432A (en) * 1985-07-31 1992-05-25 Univ Leland Stanford Junior Unicellular microorganisms having invasive capability due to exogenous inv gene and vaccines comprising such microorganisms
FI76484C (fi) 1986-02-03 1988-11-10 Osmo Norvasto Kundstol.
JPS6399020A (ja) 1986-06-05 1988-04-30 ベイラ−　カレツジ　オブ　メデイシン ワクチンとその製法
SU1723116A1 (ru) * 1988-04-15 1992-03-30 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний
DE68929405T2 (de) * 1988-09-06 2003-02-06 Washington University, St. Louis Orale-immunisierung durch verwendung von transgenen pflanzen
SE9401921D0 (sv) * 1994-06-03 1994-06-03 Sbl Vaccin Ab A method of cultivating bacteria

Also Published As

Publication number Publication date
NO307867B1 (no) 2000-06-13
CA2104877A1 (en) 1992-08-27
DE69226944D1 (de) 1998-10-15
SK280919B6 (sk) 2000-09-12
CZ174293A3 (en) 1994-04-13
WO1992014487A1 (en) 1992-09-03
BG98070A (bg) 1994-06-30
DK0573527T3 (da) 1999-06-07
DE69226944T2 (de) 1999-02-11
NO933037L (no) 1993-08-25
JP3169608B2 (ja) 2001-05-28
RU2127121C1 (ru) 1999-03-10
HU213924B (en) 1997-11-28
AU1330892A (en) 1992-09-15
AU663864B2 (en) 1995-10-26
FI933728A (fi) 1993-10-25
CZ281556B6 (cs) 1996-11-13
EP0573527A1 (en) 1993-12-15
KR100221452B1 (ko) 1999-09-15
CA2104877C (en) 2005-10-04
EP0573527B1 (en) 1998-09-09
ATE170755T1 (de) 1998-09-15
BR9205677A (pt) 1994-05-17
HUT67198A (en) 1995-02-28
BG61683B1 (bg) 1998-03-31
FI933728A0 (fi) 1993-08-25
JPH06505730A (ja) 1994-06-30
SK91093A3 (en) 1994-05-11
NO933037D0 (no) 1993-08-25
KR930703015A (ko) 1993-11-29
US6558678B1 (en) 2003-05-06
HU9302410D0 (en) 1993-11-29
RO109819B1 (ro) 1995-06-30
FI108775B (fi) 2002-03-28
OA09865A (en) 1994-08-15
ES2123550T3 (es) 1999-01-16

Similar Documents

Publication Publication Date Title
SE9100556D0 (sv) Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans
Lindberg et al. Development of an auxotrophic oral live Shigella flexneri vaccine
Cryz Jr et al. Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults
Morris Jr et al. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers
EP1702927B1 (en) Attenuated microorganisms for the treatment of infection
Arko et al. Neisseria gonorrhoeae: effects of systemic immunization on resistance of chimpanzees to urethral infection
RU93053899A (ru) Способ получения композиции вакцины, способ профилактики кишечных инфекций
JPS58501325A (ja) 腸疾患用免疫賦与性経口ワクチン
US6632439B2 (en) Fusobacterium necrophorum vaccine and method for making such vaccine
Bratthall et al. Antigenic variation of Streptococcus mutans colonizing gnotobiotic rats
KANEMORI et al. The role of extracellular protease produced by Vibrio anguillarum
Mukhopadhaya et al. Role of Shigella flexneri 2a 34 kDa outer membrane protein in induction of protective immune response
Cipriano et al. Immunization of salmonids against Yersinia ruckeri: significance of humoral immunity and cross protection between serotypes
Lasaro et al. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli
Yamaguchi et al. Antibody formation against Salmonella flagella by an immune ribonucleic acid fraction
Boesman-Finkelstein et al. Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine
US3885011A (en) Vaccine adjuvants
Fierer et al. Active immunization with LD842, a plasmid-cured strain of Salmonella dublin, protects mice against group D and group B Salmonella infection
Shaughnessy et al. Production of Potent Inactivated Vaccines with Ultraviolet Irradiation: IV. Vaccination Against Bacillary Dysentery
Yancey et al. Motility of the pathogen and intestinal immunity of the host in experimental cholera
RU2190424C1 (ru) Антигенный состав чумной химической вакцины
Chander et al. A note: polyvalent radiovaccine against Salmonella
Chen et al. Priming of Macaca cynomolgus philippinensis with purified antigen of Brucella melitensis before injection of Rev. I vaccine
IE54590B1 (en) Detoxified e. coli neurotoxin, preparation thereof and immunological preparations containing it
RU2285539C2 (ru) Молекулярная бивалентная вакцина для профилактики бруцеллеза и диарей, вызванных энтеропатогенными бактериями